SMTL ID : 2f4j.1

Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.91 Å

Oligo State

monomer

Ligands

1 x VX6: CYCLOPROPANECARBOXYLIC ACID {4-[4-(4-METHYL-PIPERAZIN-1-YL)-6-(5-METHYL-2H-PYRAZOL-3-YLAMINO)-PYRIMIDIN-2-YLSULFANYL]-PHENYL}-AMIDE(Non-covalent)

VX6.1: 18 residues within 4Å: Chain A: L.22, G.23, Y.27, V.30, A.43, K.45, E.60, V.73, I.87, T.89, E.90, F.91, M.92, T.93, Y.94, G.95, L.144, D.155 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:Y.27, A:V.30, A:V.30, A:K.45, A:I.87, A:T.89, A:F.91 Hydrogen bonds: A:T.89, A:M.92, A:M.92, A:D.155 Water bridges: A:K.45 pi-Stacking: A:Y.27

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Young, M.A. et al., Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the Aurora kinase inhibitor VX-680. Cancer Res. (2006)

Release Date

2006-01-24

Peptides

Proto-oncogene tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase ABL1